Search results
Amber Therapeutics device reduces seizures by 80% in first UK trial
Clinical Trials Arena· 5 days agoGlobalData is the parent company of Clinical Trials Arena. "Amber Therapeutics device reduces...
12 Best Audiobooks To Keep You Company This Summer: From Thrillers to Romance + More!
Woman's World· 1 day agoSo fun and witty and the friendships were so fun. Plus, Ricki was just the best character I’ve read...
Sony to Resume Operations of Acquired Japanese Crypto Firm ‘WhaleFin’
Gadgets 360· 2 hours agoJapanese tech giant Sony is gearing up to run a crypto exchange business through WhaleFin, which it...
Stocks to Buy: ICICI Bank, SBI, L&T among top 26 bottom up picks by Jefferies
Livemint· 3 days agoCheck details
Astal Laboratories Competitors List - Compare Astal Laboratories Quotes - The Economic Times
The Economic Times· 12 hours agoAstal Laboratories Competitors List - Compare Astal Laboratories with its Competitors in terms of Share Price, Stock price forecast, trends, charts and more on The Economic Times
UK: Schoolboy from southwest England first to get epilepsy device for controlling seizures
The Telegraph· 7 days agoA schoolboy from southwest England has made medical history as the first in the world with severe...
Electronics, chip firms line up Rs 3-trillion kitty over five years
Financial Express· 5 days agoEncouraged by the government’s incentive schemes, manufacturers of electronics and semiconductors...
World's first epilepsy device fitted in 13 year old UK boy's skull; Here's how the device works
The Economic Times· 6 days agoA 13-year-old boy from England has made medical history as the first person in the world with severe...
Artistic Milliners Is Scaling 3D Assets and Renewable Energy
Sourcing Journal· 3 days ago“We wanted a smooth automated workflow that would give us accurate results that are true to life and...
Top Gainers and Losers today on 26 June, 2024: Reliance Industries, Bharti Airtel, Apollo Hospitals...
Livemint· 5 days agoTop Gainers and Losers Today : The Sensex gained 620.73 points, or 0.8, to settle at 78053.52, while...